NASDAQ
Cytokinetics, Incorporated (CYTK) has a interest coverage ratio of -5.89x as of Wednesday, July 15, 2026. This represents a 14.24% increase compared to its 12-month average of -6.87x. The interest coverage ratio measures how easily a company can pay interest on its outstanding debt from operating earnings.
No price data available for this timeframe.